SCHEMBL810884

SCHEMBL810884

FC(F)(F)c1ccnc(-c2cc(C(F)(F)F)ccn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.61
NOS2 P35228 1/20 0.61
ADRB1 P08588 1/20 0.50
CCR1 P32246 2/20 0.42
CCR5 P51681 2/20 0.42
CCR8 P51685 2/20 0.42
MAPK1 P28482 2/20 0.42
ADRB2 P07550 2/20 0.41
KMO O15229 1/20 0.40
CBFB Q13951 1/20 0.40
GRM5 P41594 1/20 0.40
KIF11 P52732 1/20 0.39
NCF1 P14598 1/20 0.39
CES2 O00748 1/20 0.39
AURKA O14965 1/20 0.39
ABL1 P00519 1/20 0.38
BCR P11274 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15624407 0.91 NOS3 (0.53) NOS3NOS2ADRB1CCR1CCR5
SCHEMBL24363083 0.88 KDM4E (0.54) NOS3NOS2ADRB1CCR1CCR5
SCHEMBL16545818 0.88 CCR1 (0.65) NOS3NOS2ADRB1CCR1CCR5
SCHEMBL12074960 0.86 NOS3 (0.48) NOS3NOS2ADRB1MAPK1KIF11
SCHEMBL19258816 0.85 NOS3 (0.52) NOS3NOS2ADRB1MAPK1KMO
SCHEMBL27764812 0.85 KIF11 (0.52) NOS3NOS2KIF11ABL1BCR
SCHEMBL21386909 0.84 NOS3 (0.47) NOS3NOS2ADRB1CCR1CCR5
SCHEMBL24363113 0.84 NOS3 (0.47) NOS3NOS2ADRB1CCR1CCR5
SCHEMBL10052121 0.84 NOS3 (0.47) NOS3NOS2ADRB1ADRB2KMO
SCHEMBL2625107 0.83 ASIC3 (0.53) NOS3NOS2KMOKIF11ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120037467-A Blood contact material and preparation method thereof 上海发微医用材料有限公司 2025-05-27 CN claimed
CN-120037469-A Medical material and preparation method thereof 上海发微医用材料有限公司 2025-05-27 CN claimed
CN-120037468-A Anticoagulation medical device and preparation method thereof 上海发微医用材料有限公司 2025-05-27 CN claimed
CN-114437140-B Fluorine-containing metal iridium complex, and synthetic method and application thereof 联碳新材料技术(杭州)有限公司 2024-12-24 CN claimed
CN-114602558-B Metallic iridium photocatalyst and preparation method and application thereof 联碳新材料技术(杭州)有限公司 2023-10-31 CN claimed
WO-2023087843-A1 NEUTRAL IRIDIUM COMPLEX CONTAINING NITROGEN-SULFUR FOUR-MEMBERED RING COORDINATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏科技大学 2023-05-25 WO claimed
US-20220259240-A1 PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2022-08-18 US claimed
EP-4013764-A1 PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES Johnson Matthey Public Limited Company (GB) 2022-06-22 EP claimed
CN-114507259-A Transition metal iridium complex photocatalyst and preparation method and application thereof 联碳新材料技术(杭州)有限公司 2022-05-17 CN claimed
CN-114478649-A Iridium complex with photocatalytic performance, and preparation method and application thereof 联碳新材料技术(杭州)有限公司 2022-05-13 CN claimed
CN-114437140-A Fluorine-containing metal iridium complex and synthesis method and application thereof 联碳新材料技术(杭州)有限公司 2022-05-06 CN claimed
WO-2021032952-A1 PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2021-02-25 WO claimed
US-20260055128-A1 ORGANONICKEL INTERMEDIATES USEFUL FOR CARBOXYLATION OF SUBSTRATES WITH CARBON DIOXIDE U.S. DEPARTMENT OF ENERGY 2026-02-26 US disclosed
CN-120037468-A Anticoagulation medical device and preparation method thereof 上海发微医用材料有限公司 2025-05-27 CN disclosed
CN-120037469-A Medical material and preparation method thereof 上海发微医用材料有限公司 2025-05-27 CN disclosed
CN-120037467-A Blood contact material and preparation method thereof 上海发微医用材料有限公司 2025-05-27 CN disclosed
EP-2390241-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2011-11-30 EP disclosed
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2011-11-10 US disclosed
US-20110256790-A1 THERMAL INSULATION CONTAINING SUPPLEMENTAL INFRARED RADIATION ABSORBING MATERIAL SAINT-GOBAIN ISOVER (FR) 2011-10-20 US disclosed
US-7361414-B2 Light emitting device and display apparatus using same CANON KABUSHIKI KAISHA (JP) 2008-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND C9, H1-10, CYP1A1 NOS3 2458/4885NOS2 2141/4885ADRB1 1208/4885
US-20220259240-A1 PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES RUVBL1, RUVBL2, RPP30 NOS3 644/4885NOS2 2087/4885ADRB1 672/4885
US-20260055128-A1 ORGANONICKEL INTERMEDIATES USEFUL FOR CARBOXYLATION OF SUBSTRATES WITH CARBON DIOXIDE MT-CO2, SCO2, ACACA NOS3 948/4885NOS2 802/4885ADRB1 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.